The Development of Vδ1 Gamma Delta T cell Platforms For Use In Next-Generation Allogeneic CAR Therapies

Time: 3:45 pm
day: Conference Day Two

Details:

  • Harnessing the potential of γδ T cells for immunotherapy in solid and hematological malignancies
  • Investigating the advancements of allogeneic Vδ1 γδ T cell therapy platforms
  • Preclinical update on the progress of cell therapy programs utilizing Vδ1 γδ T cells

Speakers: